Vectorized Antibodies
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global TCR-Based Antibody Market Research Report 2023
1 TCR-Based Antibody Market Overview
1.1 Product Overview and Scope of TCR-Based Antibody
1.2 TCR-Based Antibody Segment by Type
1.2.1 Global TCR-Based Antibody Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 NY-ESO-1
1.2.3 p53
1.2.4 WT-1
1.2.5 EBv
1.2.6 Others
1.3 TCR-Based Antibody Segment by Application
1.3.1 Global TCR-Based Antibody Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Pharma and Biotech Research Laboratories.
1.3.5 Gene Therapy Centers
1.3.6 Others
1.4 Global TCR-Based Antibody Market Size Estimates and Forecasts
1.4.1 Global TCR-Based Antibody Revenue 2017-2028
1.4.2 Global TCR-Based Antibody Sales 2017-2028
1.4.3 TCR-Based Antibody Market Size by Region: 2017 Versus 2021 Versus 2028
2 TCR-Based Antibody Market Competition by Manufacturers
2.1 Global TCR-Based Antibody Sales Market Share by Manufacturers (2017-2022)
2.2 Global TCR-Based Antibody Revenue Market Share by Manufacturers (2017-2022)
2.3 Global TCR-Based Antibody Average Price by Manufacturers (2017-2022)
2.4 Manufacturers TCR-Based Antibody Manufacturing Sites, Area Served, Product Type
2.5 TCR-Based Antibody Market Competitive Situation and Trends
2.5.1 TCR-Based Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest TCR-Based Antibody Players Market Share by Revenue
2.5.3 Global TCR-Based Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TCR-Based Antibody Retrospective Market Scenario by Region
3.1 Global TCR-Based Antibody Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global TCR-Based Antibody Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America TCR-Based Antibody Market Facts & Figures by Country
3.3.1 North America TCR-Based Antibody Sales by Country
3.3.2 North America TCR-Based Antibody Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe TCR-Based Antibody Market Facts & Figures by Country
3.4.1 Europe TCR-Based Antibody Sales by Country
3.4.2 Europe TCR-Based Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific TCR-Based Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific TCR-Based Antibody Sales by Region
3.5.2 Asia Pacific TCR-Based Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America TCR-Based Antibody Market Facts & Figures by Country
3.6.1 Latin America TCR-Based Antibody Sales by Country
3.6.2 Latin America TCR-Based Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa TCR-Based Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa TCR-Based Antibody Sales by Country
3.7.2 Middle East and Africa TCR-Based Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global TCR-Based Antibody Historic Market Analysis by Type
4.1 Global TCR-Based Antibody Sales Market Share by Type (2017-2022)
4.2 Global TCR-Based Antibody Revenue Market Share by Type (2017-2022)
4.3 Global TCR-Based Antibody Price by Type (2017-2022)
5 Global TCR-Based Antibody Historic Market Analysis by Application
5.1 Global TCR-Based Antibody Sales Market Share by Application (2017-2022)
5.2 Global TCR-Based Antibody Revenue Market Share by Application (2017-2022)
5.3 Global TCR-Based Antibody Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Adaptimmune Therapeutics
6.1.1 Adaptimmune Therapeutics Corporation Information
6.1.2 Adaptimmune Therapeutics Description and Business Overview
6.1.3 Adaptimmune Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Adaptimmune Therapeutics TCR-Based Antibody Product Portfolio
6.1.5 Adaptimmune Therapeutics Recent Developments/Updates
6.2 Celgene
6.2.1 Celgene Corporation Information
6.2.2 Celgene Description and Business Overview
6.2.3 Celgene TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Celgene TCR-Based Antibody Product Portfolio
6.2.5 Celgene Recent Developments/Updates
6.3 Immunocore
6.3.1 Immunocore Corporation Information
6.3.2 Immunocore Description and Business Overview
6.3.3 Immunocore TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Immunocore TCR-Based Antibody Product Portfolio
6.3.5 Immunocore Recent Developments/Updates
6.4 Kuur Therapeutics
6.4.1 Kuur Therapeutics Corporation Information
6.4.2 Kuur Therapeutics Description and Business Overview
6.4.3 Kuur Therapeutics TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Kuur Therapeutics TCR-Based Antibody Product Portfolio
6.4.5 Kuur Therapeutics Recent Developments/Updates
6.5 Lion TCR
6.5.1 Lion TCR Corporation Information
6.5.2 Lion TCR Description and Business Overview
6.5.3 Lion TCR TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Lion TCR TCR-Based Antibody Product Portfolio
6.5.5 Lion TCR Recent Developments/Updates
6.6 Kite Pharma
6.6.1 Kite Pharma Corporation Information
6.6.2 Kite Pharma Description and Business Overview
6.6.3 Kite Pharma TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Kite Pharma TCR-Based Antibody Product Portfolio
6.6.5 Kite Pharma Recent Developments/Updates
6.7 Takara Bio
6.6.1 Takara Bio Corporation Information
6.6.2 Takara Bio Description and Business Overview
6.6.3 Takara Bio TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Takara Bio TCR-Based Antibody Product Portfolio
6.7.5 Takara Bio Recent Developments/Updates
6.8 Ziopharm Oncology
6.8.1 Ziopharm Oncology Corporation Information
6.8.2 Ziopharm Oncology Description and Business Overview
6.8.3 Ziopharm Oncology TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Ziopharm Oncology TCR-Based Antibody Product Portfolio
6.8.5 Ziopharm Oncology Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GlaxoSmithKline TCR-Based Antibody Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Merck
6.10.1 Merck Corporation Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Merck TCR-Based Antibody Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Juno Theraprutics
6.11.1 Juno Theraprutics Corporation Information
6.11.2 Juno Theraprutics TCR-Based Antibody Description and Business Overview
6.11.3 Juno Theraprutics TCR-Based Antibody Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Juno Theraprutics TCR-Based Antibody Product Portfolio
6.11.5 Juno Theraprutics Recent Developments/Updates
7 TCR-Based Antibody Manufacturing Cost Analysis
7.1 TCR-Based Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of TCR-Based Antibody
7.4 TCR-Based Antibody Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 TCR-Based Antibody Distributors List
8.3 TCR-Based Antibody Customers
9 TCR-Based Antibody Market Dynamics
9.1 TCR-Based Antibody Industry Trends
9.2 TCR-Based Antibody Market Drivers
9.3 TCR-Based Antibody Market Challenges
9.4 TCR-Based Antibody Market Restraints
10 Global Market Forecast
10.1 TCR-Based Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of TCR-Based Antibody by Type (2023-2028)
10.1.2 Global Forecasted Revenue of TCR-Based Antibody by Type (2023-2028)
10.2 TCR-Based Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of TCR-Based Antibody by Application (2023-2028)
10.2.2 Global Forecasted Revenue of TCR-Based Antibody by Application (2023-2028)
10.3 TCR-Based Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of TCR-Based Antibody by Region (2023-2028)
10.3.2 Global Forecasted Revenue of TCR-Based Antibody by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global TCR-Based Antibody Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global TCR-Based Antibody Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global TCR-Based Antibody Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global TCR-Based Antibody Market Competitive Situation by Manufacturers in 2021
Table 5. Global TCR-Based Antibody Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global TCR-Based Antibody Sales Market Share by Manufacturers (2017-2022)
Table 7. Global TCR-Based Antibody Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global TCR-Based Antibody Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market TCR-Based Antibody Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers TCR-Based Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers TCR-Based Antibody Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global TCR-Based Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR-Based Antibody as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global TCR-Based Antibody Sales by Region (2017-2022) & (K Units)
Table 16. Global TCR-Based Antibody Sales Market Share by Region (2017-2022)
Table 17. Global TCR-Based Antibody Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global TCR-Based Antibody Revenue Market Share by Region (2017-2022)
Table 19. North America TCR-Based Antibody Sales by Country (2017-2022) & (K Units)
Table 20. North America TCR-Based Antibody Sales Market Share by Country (2017-2022)
Table 21. North America TCR-Based Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America TCR-Based Antibody Revenue Market Share by Country (2017-2022)
Table 23. Europe TCR-Based Antibody Sales by Country (2017-2022) & (K Units)
Table 24. Europe TCR-Based Antibody Sales Market Share by Country (2017-2022)
Table 25. Europe TCR-Based Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe TCR-Based Antibody Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific TCR-Based Antibody Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific TCR-Based Antibody Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific TCR-Based Antibody Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific TCR-Based Antibody Revenue Market Share by Region (2017-2022)
Table 31. Latin America TCR-Based Antibody Sales by Country (2017-2022) & (K Units)
Table 32. Latin America TCR-Based Antibody Sales Market Share by Country (2017-2022)
Table 33. Latin America TCR-Based Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America TCR-Based Antibody Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa TCR-Based Antibody Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa TCR-Based Antibody Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa TCR-Based Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa TCR-Based Antibody Revenue Market Share by Country (2017-2022)
Table 39. Global TCR-Based Antibody Sales by Type (2017-2022) & (K Units)
Table 40. Global TCR-Based Antibody Sales Market Share by Type (2017-2022)
Table 41. Global TCR-Based Antibody Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global TCR-Based Antibody Revenue Share by Type (2017-2022)
Table 43. Global TCR-Based Antibody Price by Type (2017-2022) & (US$/Unit)
Table 44. Global TCR-Based Antibody Sales (K Units) by Application (2017-2022)
Table 45. Global TCR-Based Antibody Sales Market Share by Application (2017-2022)
Table 46. Global TCR-Based Antibody Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global TCR-Based Antibody Revenue Share by Application (2017-2022)
Table 48. Global TCR-Based Antibody Price by Application (2017-2022) & (US$/Unit)
Table 49. Adaptimmune Therapeutics Corporation Information
Table 50. Adaptimmune Therapeutics Description and Business Overview
Table 51. Adaptimmune Therapeutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Adaptimmune Therapeutics TCR-Based Antibody Product
Table 53. Adaptimmune Therapeutics Recent Developments/Updates
Table 54. Celgene Corporation Information
Table 55. Celgene Description and Business Overview
Table 56. Celgene TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Celgene TCR-Based Antibody Product
Table 58. Celgene Recent Developments/Updates
Table 59. Immunocore Corporation Information
Table 60. Immunocore Description and Business Overview
Table 61. Immunocore TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Immunocore TCR-Based Antibody Product
Table 63. Immunocore Recent Developments/Updates
Table 64. Kuur Therapeutics Corporation Information
Table 65. Kuur Therapeutics Description and Business Overview
Table 66. Kuur Therapeutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Kuur Therapeutics TCR-Based Antibody Product
Table 68. Kuur Therapeutics Recent Developments/Updates
Table 69. Lion TCR Corporation Information
Table 70. Lion TCR Description and Business Overview
Table 71. Lion TCR TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Lion TCR TCR-Based Antibody Product
Table 73. Lion TCR Recent Developments/Updates
Table 74. Kite Pharma Corporation Information
Table 75. Kite Pharma Description and Business Overview
Table 76. Kite Pharma TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Kite Pharma TCR-Based Antibody Product
Table 78. Kite Pharma Recent Developments/Updates
Table 79. Takara Bio Corporation Information
Table 80. Takara Bio Description and Business Overview
Table 81. Takara Bio TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Takara Bio TCR-Based Antibody Product
Table 83. Takara Bio Recent Developments/Updates
Table 84. Ziopharm Oncology Corporation Information
Table 85. Ziopharm Oncology Description and Business Overview
Table 86. Ziopharm Oncology TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Ziopharm Oncology TCR-Based Antibody Product
Table 88. Ziopharm Oncology Recent Developments/Updates
Table 89. GlaxoSmithKline Corporation Information
Table 90. GlaxoSmithKline Description and Business Overview
Table 91. GlaxoSmithKline TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. GlaxoSmithKline TCR-Based Antibody Product
Table 93. GlaxoSmithKline Recent Developments/Updates
Table 94. Merck Corporation Information
Table 95. Merck Description and Business Overview
Table 96. Merck TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Merck TCR-Based Antibody Product
Table 98. Merck Recent Developments/Updates
Table 99. Juno Theraprutics Corporation Information
Table 100. Juno Theraprutics Description and Business Overview
Table 101. Juno Theraprutics TCR-Based Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Juno Theraprutics TCR-Based Antibody Product
Table 103. Juno Theraprutics Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. TCR-Based Antibody Distributors List
Table 107. TCR-Based Antibody Customers List
Table 108. TCR-Based Antibody Market Trends
Table 109. TCR-Based Antibody Market Drivers
Table 110. TCR-Based Antibody Market Challenges
Table 111. TCR-Based Antibody Market Restraints
Table 112. Global TCR-Based Antibody Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global TCR-Based Antibody Sales Market Share Forecast by Type (2023-2028)
Table 114. Global TCR-Based Antibody Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global TCR-Based Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global TCR-Based Antibody Sales Forecast by Application (2023-2028) & (K Units)
Table 117. Global TCR-Based Antibody Sales Market Share Forecast by Application (2023-2028)
Table 118. Global TCR-Based Antibody Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global TCR-Based Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global TCR-Based Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global TCR-Based Antibody Sales Market Share Forecast by Region (2023-2028)
Table 122. Global TCR-Based Antibody Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global TCR-Based Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of TCR-Based Antibody
Figure 2. Global TCR-Based Antibody Market Share by Type in 2021 & 2028
Figure 3. NY-ESO-1 Product Picture
Figure 4. p53 Product Picture
Figure 5. WT-1 Product Picture
Figure 6. EBv Product Picture
Figure 7. Others Product Picture
Figure 8. Global TCR-Based Antibody Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Specialized Clinics
Figure 11. Pharma and Biotech Research Laboratories.
Figure 12. Gene Therapy Centers
Figure 13. Others
Figure 14. Global TCR-Based Antibody Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global TCR-Based Antibody Market Size (2017-2028) & (US$ Million)
Figure 16. Global TCR-Based Antibody Sales (2017-2028) & (K Units)
Figure 17. TCR-Based Antibody Sales Share by Manufacturers in 2021
Figure 18. Global TCR-Based Antibody Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest TCR-Based Antibody Players: Market Share by Revenue in 2021
Figure 20. TCR-Based Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global TCR-Based Antibody Sales Market Share by Region (2017-2022)
Figure 22. Global TCR-Based Antibody Sales Market Share by Region in 2021
Figure 23. Global TCR-Based Antibody Revenue Market Share by Region (2017-2022)
Figure 24. Global TCR-Based Antibody Revenue Market Share by Region in 2021
Figure 25. United States TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. China Taiwan TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Colombia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE TCR-Based Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of TCR-Based Antibody by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of TCR-Based Antibody
Figure 50. Manufacturing Process Analysis of TCR-Based Antibody
Figure 51. TCR-Based Antibody Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adaptimmune Therapeutics Celgene Immunocore Kuur Therapeutics Lion TCR Kite Pharma Takara Bio Ziopharm Oncology GlaxoSmithKline Merck Juno Theraprutics